Andreas Bergmann

B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany.

HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US.

Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.

Moody's Deutschland GmbH is the Germany-based investment research subsidiary of Moody’s Corp. (NYSE: MCO) in the US. Headquartered in Frankfurt, the firm was founded in 1991 and provides credit ratings, research, risk analyzes and default data to German-speaking clients including banks, insurance companies, asset managers and industrial companies in Germany, Austria and Switzerland.

PhotonPharma, Inc. is developing the Innocell therapeutic cancer vaccine, which is a personalized therapy using autologous tumor tissue. The company is based in Fort Collins, CO at the Research Innovation Center of Colorado State University. The technology is based on a photochemical inactivation platform that uses riboflavin (vitamin B2) and UV light to render tumor cells incapable of replication while still allowing them to metabolize, express proteins, present antigens, and stimulate immune recognition and response mechanisms. In combination with selected adjuvants, Innocell has shown the ability to prevent metastatic tumor formation, reduce tumor growth, and stimulate cellular immune response pathways in preclinical animal models. The company was founded in 2018 by Raymond Goodrich, and Alan S. Rudolph has been the CEO since 2018.

Boehringer Ingelheim RCV GmbH & Co. KG develops and supplies biotherapeutic proteins, plasmid DNA and antibody fragments. The company was founded in 1885 by Albert Boehringer and is headquartered in Vienna, Austria.

Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto.

Harren Maritime Services GmbH engages in the provision of services for companies in the maritime sector. These include the management of trading companies, brokerage of commercial transactions, and business consulting. The company was founded on September 2, 2009 and is headquartered in Haren, Germany.

Emperra GmbH E-Health Technologies manufactures and designs telemedicine technologies. The firm specializes in the development of medical monitoring devices for the tracking and transmission of diabetic patients' diagnostic and therapeutic data. It develops components and systems under the ESYSTA product brand, featuring data acquisition, analysis, and transfer solutions. The company was founded by Janko Schildt in 2008 and is headquartered in Potsdam, Germany.

Caterna Vision GmbH provides and develops technologies for the vision therapy. It develops and markets treatment software for therapeutic applications in ophthalmology. The firm’s product is used in the treatment of amblyopia. The company founded by Nicolaus Widera and Sascha Seewald in 2013 and is headquartered in Berlin, Germany.

High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany.

bmp Ventures /Venture Capital/ (bmp Ventures) is the venture capital arm of bmp Ventures AG. It was founded by Oliver Borrmann in 1997. The firm is headquartered in Berlin, Germany, with another German office located in Magdeburg.

Beteiligungsgesellschaft Sachsen-Anhalt mbH is a private equity/ venture capital firm founded in 1996. The firm is headquartered in Magedeburg.

Part of Harren Shipping Services GmbH & Co. KG, Sia "AMANDO" UG (haftungsbeschränkt) & Co. KG is a deep sea transportation company based in Haren, Germany. Sia "AMANDO" UG (haftungsbeschränkt) & Co. KG provides deep sea transportation services. The German company was founded in 2006 and is led by CEOs Bernhard Held, Peter Harren, and Martin Harren.

Harren & Partner Schiffahrts GmbH & Co. KG MS PALMERTON provides cargo shipping services. The private company is based in Haren, Germany. The CEOs of the German company are Bernhard Held, Martin Harren.

Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden.

InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom.

H&P Shipping Portfolio Panmax Bulk Carrier GmbH & Co. KG provides administration and management services. The CEOs are Bernhard Held, Martin Harren. The German company was founded in 2012.

SAL Shipping UG (haftungsbeschränkt) & Co. KG MS TRINA is a shipping private company based in Haren, Germany. SAL Shipping UG provides shipping services. The German company was founded in 2017, and its CEOs are Bernhard Held and Martin Harren.

Harren & Partner Schiffahrts GmbH & Co. KG MS "PATARA" is a German company that provides freight transport services by sea. The private company is based in Haren, Germany. The CEOs of the company are Bernhard Held, Martin Harren.

Part of Harren & Partner Schiffahrts GmbH & Co. KG, Harren & Partner Schiffahrts GmbH & Co. KG MS "PANJANG" is a German company that provides maritime and coastal freight transportation services. The company is based in Haren, Germany. The CEOs of the company are Bernhard Held, Martin Harren.

Harren & Partner Schiffahrts GmbH & Co. KG MS "PATAGONIA" provides deep sea freight transportation services. The private company is based in Haren, Germany. The CEOs of the German company are Bernhard Held, Martin Harren.

Harren & Partner Schiffahrts GmbH & Co. KG MS PAFILIA is a German company that provides sea and coastal freight transportation services. The private company is based in Haren, Germany. The CEOs of the company are Bernhard Held, Martin Harren.

MS "Dutch Verena" Shipping GmbH & Co. KG provides sea and coastal shipping freight transportation services. The private company is based in Haren, Germany. The CEOs of the German company are Bernhard Held, Nils Hendrik Boese.

Part of Harren & Partner Schiffahrts GmbH & Co. KG, Harren & Partner Schiffahrts GmbH & Co. KG MS "PACOBA" provides freight transportation in maritime and coastal shipping. The company is based in Haren, Germany. The CEOs of the German company are Bernhard Held, Martin Harren.

Harren & Partner PROJECT CARRIER I Beteiligungs GmbH & Co. KG provides management services. The private company is based in Haren, Germany. The CEOs are Bernhard Held, Martin Harren. The German company was founded in 2008.

MarShip Minibulker Flotte GmbH & Co. KG provides seagoing vessel management and sale services. The private company is based in Haren, Germany. The CEO of the German company is Bernhard Held.

Mahzi Therapeutics is a private biotechnology company that focuses on genetic therapies for rare genetic neurodevelopmental disorders. The company was founded by Yael Weiss and is based in San Mateo, CA. The company unites patient and family groups, academic researchers, diagnostic companies, other industry members, and its internal team of experts to develop therapies for patients with these serious diseases. Mahzi's team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases. Yael Weiss has been the CEO since incorporation.